Opsoclonus myoclonus syndrome: Response to plasmapheresis

Indian Pediatrics

Volumn 41, Issue 5, 2004, Pages 499-502

  Sheela, S R ^a,c   Mani, P J ^b  

^a Indira Gandhi Co operative Hospital   (India)

^b Lourdes Hospital   (India)

^c NONE   (India)

Author keywords

Antineuronal antibodies; Opsoclonus myoclonus syndrome; Plasmapheresis

Indexed keywords

AZATHIOPRINE; CLONAZEPAM; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADRENAL TUMOR; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CORTICOSTEROID THERAPY; FEMALE; GANGLIONEUROMA; HUMAN; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYOCLONUS; OPSOCLONUS; PLASMAPHERESIS; PRESCHOOL CHILD; SYNDROME DELINEATION; TREATMENT OUTCOME;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; PLASMAPHERESIS;

EID: 2542427353     PISSN: 00196061     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yiu VWY, Kovithavongs T, McGonigle LF, Ferriera P. Plasmapheresis as an effective treatment for idiopathic opsoclonus-myoclonus syndrome. Pediatr Neurol 2001; 24: 72-74.
2. Bataller L, Rosenfeld MR, Graus F, Vilchez JJ, Cheung V, Dalmau J. Autoantigen diversity in the opsoclonus myoclonus syndrome. Ann Neurol 2003; 53: 347-353.
3. Pranzatelli MR. The immunopharmacology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1996; 19: 1-47.
4. Noetzel M, Cawley LP, James VL, Minard BJ, Agarwal HC. Antineurofilament protein antibodies in opsoclonus-myoclonus. J Neuroimmunol 1987; 15: 137-145
5. Connolly AM, Pestronk A, Mehta S, Pranzatelli MR, Noetzel MJ. Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues. J Pediatr 1997; 130: 878-884.
6. Kinsbourne M. Myoclonic encephalopathy of infants. J Neurol Neurosurg Psychiatry 1962; 25: 271-276.
7. Munck A, Guyre PM. Glucocorticoids and immune function. In: Psychopharmacology. Eds. Ader R, Felten DL, Cohen N. San Diego, Acadamic Press, 1991; pp 447-472
8. Cher LM, Hochberg FH, Teruya J. Therapy for paraneoplastic syndromes in six patients with protein A column immunoadsorption. Cancer 1995; 75: 1678-1683.
9. Graus F, Abos J, Roquer J, Mazzara R, Pereira A. Effect of plasmapheresis on serum and CSF antibody levels in paraneoplastic syndromes. Neurology 1990; 40: 1621-1623.
10. Schroeder JD, Euler HH. Antibody rebound after plasmapheresis: Experimental endemic and clinical consequences. Prog Clin Biol Res 1990; 337: 415-417.
11. Ulrichs K, Euler HH, Schroeder JO, Muller-Ruchkoltz W. Long-term suppression of antibody production by plasmapheresis and a short course of cyclophosphamide. Transpl Proc 1992; 24: 705-706.